当前位置:首页 - 行情中心 - 鱼跃医疗(002223) - 财务分析 - 现金流量表

鱼跃医疗

(002223)

  

流通市值:246.04亿  总市值:261.89亿
流通股本:9.34亿   总股本:9.95亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,724,922,970.962,337,089,006.098,446,976,414.86,608,481,380.28
  收到的税费返还49,531,263.1224,628,296.95125,258,728.7380,186,352.08
  收到其他与经营活动有关的现金191,579,762.77144,956,920.22436,519,015.28457,714,416.57
  经营活动现金流入小计4,966,033,996.852,506,674,223.269,008,754,158.817,146,382,148.93
  购买商品、接受劳务支付的现金1,790,877,174.48879,023,035.713,592,983,429.872,542,105,028.62
  支付给职工以及为职工支付的现金773,819,771.99455,517,076.581,429,181,740.051,047,524,577.83
  支付的各项税费369,969,729.94112,798,055.52733,592,109.83750,736,983.24
  支付其他与经营活动有关的现金849,208,908.6462,224,618.981,750,075,163.271,302,514,887.79
  经营活动现金流出小计3,783,875,585.011,909,562,786.797,505,832,443.025,642,881,477.48
  经营活动产生的现金流量净额1,182,158,411.84597,111,436.471,502,921,715.791,503,500,671.45
二、投资活动产生的现金流量:
  收回投资收到的现金69,855,644.783,448,275.839,273,034.369,380,409.36
  取得投资收益收到的现金20,436,306.174,827,586.1756,211,37356,113,760.81
  处置固定资产、无形资产和其他长期资产收回的现金净额273,126,958.64,30075,932,363.3375,254,535.9
  收到的其他与投资活动有关的现金520,000,000---
  投资活动现金流入小计883,418,909.558,280,162141,416,770.69140,748,706.07
  购建固定资产、无形资产和其他长期资产支付的现金49,788,635.0527,790,853.99128,981,496.52102,287,711.59
  投资支付的现金2,043,037.95-260,912,035.33270,935,060.22
  支付其他与投资活动有关的现金448,832,800178,832,8006,403,545,608.02-
  投资活动现金流出小计500,664,473206,623,653.996,793,439,139.87373,222,771.81
  投资活动产生的现金流量净额382,754,436.55-198,343,491.99-6,652,022,369.18-232,474,065.74
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金-5,336,538.8-9,701,657.1
  筹资活动现金流入平衡项目-0-0
  筹资活动现金流入小计-5,336,538.8-9,701,657.1
  偿还债务支付的现金12,527,412.15-20,866,190.21-
  分配股利、利润或偿付利息支付的现金601,486,157.4-799,010,395.35399,742,211.64
  支付其他与筹资活动有关的现金126,988,255.877,367,804.141,941,120.4312,681,001.35
  筹资活动现金流出小计741,001,825.427,367,804.14821,817,705.99412,423,212.99
  筹资活动产生的现金流量净额-741,001,825.42-2,031,265.34-821,817,705.99-402,721,555.89
四、汇率变动对现金及现金等价物的影响-42,434,176.04-34,154,362.67-51,975,920.09-21,220,102.32
五、现金及现金等价物净增加额781,476,846.93362,582,316.47-6,022,894,279.47847,084,947.5
  加:期初现金及现金等价物余额573,104,129.45573,104,129.456,595,998,408.926,595,998,408.92
  期末现金及现金等价物余额1,354,580,976.38935,686,445.92573,104,129.457,443,083,356.42
补充资料:
  净利润847,869,043.23-1,484,136,250.87-
  资产减值准备28,201,119.75-33,472,241.75-
  固定资产和投资性房地产折旧96,583,906.96-194,087,512.34-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧96,583,906.96-194,087,512.34-
  无形资产摊销18,777,638.83-45,093,871.94-
  长期待摊费用摊销32,620,937.84-53,047,910.71-
  处置固定资产、无形资产和其他长期资产的损失236,451.13--1,281,395.38-
  固定资产报废损失326,996.45-1,300,431.57-
  财务费用82,598,786.19--32,529,930.72-
  投资损失-18,236,442.79--34,149,903.34-
  递延所得税-4,350,159.33--1,653,839.83-
  其中:递延所得税资产减少11,065,204.17-3,157,628.21-
    递延所得税负债增加-15,415,363.5--4,811,468.04-
  存货的减少151,648,543.35--56,783,515.72-
  经营性应收项目的减少-279,743,209.58-157,281,765.51-
  经营性应付项目的增加211,666,272.33--358,667,405.04-
  其他2,000,231.54--6,607,260.62-
  现金的期末余额1,354,580,976.38-573,104,129.45-
  减:现金的期初余额573,104,129.45-6,595,998,408.92-
  现金及现金等价物的净增加额781,476,846.93--6,022,894,279.47-
公告日期2026-08-222026-04-252026-04-252025-10-25
审计意见(境内)标准无保留意见
TOP↑